Our Accomplishments

$20 Million Clinical Translational Science Award Opens Doors to Greater Collaboration between MUSC, Clemson and HSSC

Grants

In July, the National Institute of Health (NIH) selected the Medical University of South Carolina (MUSC) for a Clinical Translational Science Award (CTSA), an award that comes with $20 million for translational research over the next five years.

The CTSA grant is among the most prestigious award made to medical universities. The NIH has just 60 CTSA grants to award before 2012. In the Southeast, the are only six CTSA grant holders: the University of Alabama-Birmingham, the University of North Carolina, Duke University, Emory University, Vanderbilt University, and MUSC. At the press conference announcing the award, MUSC President Ray Greenberg congratulated the MUSC team of more than 200 faculty and staff members led by CTSA co-principal investigators Kathleen Brady, MD, PhD, and Perry Halushka, MD, PhD. He thanked partners USC, Clemson, HSSC, Claflin University, Greenwood Genetics Center, and SCRA for their help in securing the award. He also recognize the South Carolina General Assembly and the SmartState Centers.

The CTSA grant opens the door to greater collaboration between MUSC and its in-state partners, including HSSC. It enables South Carolina researchers to play a larger, national role in improving the lives of patients across a spectrum of diseases. The $20 million CTSA grant is an economic win for the state as well. In addition to jobs created directly by the CTSA, research and clinical success from CTSA will result in more biotechnology transfer and spin-off companies and contribute to South Carolina’s knowledge-based economy.

Snapshot

Accomplishment Data

Organizations: Theme:
  • Recognition
Focus:
  • Clinicians
    Health Care Systems
    Communities
    Consumers
    Research Organizations
    Researchers